Ranbaxy Laboratories Ltd had earlier informed to the Stock Exchanges that the Company has filed a complaint against the US FDA in D.C. Federal Court and had also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxys case is decided.
Ranbaxy Laboratories Ltd further submitted, 'The Court has not granted Temporary Restraining Order to block FDA approval for other ANDAs for generic version of Nexium and Valganciclovir. However, the Court ordered the parties to the suit to agree up on a schedule for filing additional legal briefs addressing Ranbaxys request for a preliminary injunction by Friday, November 21, 2014.'
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
